Recommendations for a national agenda to substantially reduce cervical cancer

[1]  C. Farrell,et al.  Task Force , 2021, Across the Generations.

[2]  Virginia Moyer,et al.  The US Preventive Services Task Force , 2015, North Carolina Medical Journal.

[3]  S. Stokley,et al.  National human papillomavirus vaccination coverage among adolescents aged 13-17 years-National Immunization Survey--teen, United States, 2011. , 2014, MMWR supplements.

[4]  K. Winch,et al.  Utility of reports and routine correspondence from the National HPV Vaccination Program Register , 2013, The Medical journal of Australia.

[5]  N. Brewer,et al.  Early lessons learned from extramural school programs that offer HPV vaccine. , 2013, The Journal of school health.

[6]  U. P. S. T. Force.  Screening for cervical cancer: recommendation statement. , 2012, American family physician.

[7]  J. Pepper,et al.  Improving human papillomavirus vaccine delivery: a national study of parents and their adolescent sons. , 2012, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[8]  V. Moyer,et al.  Screening for Cervical Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.

[9]  L. Dickinson,et al.  Effectiveness and Cost of Immunization Recall at School-Based Health Centers , 2012, Pediatrics.

[10]  M. Schiffman,et al.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer , 2012 .

[11]  Benjamin D. Sommers,et al.  Reasons for the wide variation in Medicaid participation rates among states hold lessons for coverage expansion in 2014. , 2012, Health affairs.

[12]  A. Giuliano,et al.  Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. , 2011, Vaccine.

[13]  N. Brewer,et al.  Acceptability of school requirements for human papillomavirus vaccine , 2011, Human vaccines.

[14]  Zahava Berkowitz,et al.  Low-Risk Human Papillomavirus Testing and Other Nonrecommended Human Papillomavirus Testing Practices Among U.S. Health Care Providers , 2011, Obstetrics and gynecology.

[15]  R. Robertson,et al.  Women at risk: why increasing numbers of women are failing to get the health care they need and how the Affordable Care Act will help. Findings from the Commonwealth Fund Biennial Health Insurance Survey of 2010. , 2011, Issue brief.

[16]  N. Brewer,et al.  Longitudinal Predictors of Human Papillomavirus Vaccine Initiation Among Adolescent Girls in a High-Risk Geographic Area , 2011, Sexually transmitted diseases.

[17]  T. Weiss,et al.  Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. , 2011, Vaccine.

[18]  M. Naus,et al.  A Population-Based Evaluation of a Publicly Funded, School-Based HPV Vaccine Program in British Columbia, Canada: Parental Factors Associated with HPV Vaccine Receipt , 2010, PLoS medicine.

[19]  N Cheal,et al.  Breast and cervical cancer screening in minority populations: a model for using lay health educators. , 2009, Journal of cancer education : the official journal of the American Association for Cancer Education.

[20]  Joakim Dillner,et al.  Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. , 2008, Vaccine.

[21]  T. Johnson,et al.  Accuracy of Self-Reported Cancer-Screening Histories: A Meta-analysis , 2008, Cancer Epidemiology Biomarkers & Prevention.

[22]  Diane Solomon,et al.  2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. , 2007, American journal of obstetrics and gynecology.

[23]  E. Franco,et al.  Process of care failures in invasive cervical cancer: systematic review and meta-analysis. , 2007, Preventive medicine.

[24]  S. Franceschi,et al.  Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update , 2007, International journal of cancer.

[25]  Noel T Brewer,et al.  Predictors of HPV vaccine acceptability: a theory-informed, systematic review. , 2007, Preventive medicine.

[26]  M. Schiffman.  Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing , 2007, Cancer.

[27]  Jennifer S. Smith,et al.  Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. , 2007, Current problems in cancer.

[28]  A. Coker,et al.  Understanding barriers for adherence to follow-up care for abnormal pap tests. , 2007, Journal of women's health.

[29]  L. Neinstein,et al.  Adolescent immunizations: a position paper of the Society for Adolescent Medicine. , 2006, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[30]  P. Szilagyi,et al.  Patient reminder and recall systems to improve immunization rates , 2005 .

[31]  M. Manos,et al.  Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. , 2005, Journal of the National Cancer Institute.

[32]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[33]  R. Hiatt,et al.  Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan , 2000, Journal of lower genital tract disease.

[34]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[35]  R. Hiatt,et al.  Missed opportunities for cervical cancer screening of HMO members developing invasive cervical cancer (ICC). , 1998, Gynecologic oncology.

[36]  C Milligan,et al.  Screening for cervical cancer. , 1975, The American journal of nursing.

[37]  National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011. , 2012, MMWR. Morbidity and mortality weekly report.

[38]  J. Dungan.  Low-Risk Human Papillomavirus Testing and Other Nonrecommended Human Papillomavirus Testing Practices Among U.S. Health Care Providers , 2012 .

[39]  Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011. , 2011, MMWR. Morbidity and mortality weekly report.

[40]  FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). , 2010, MMWR. Morbidity and mortality weekly report.

[41]  ACOG Practice Bulletin no. 109: Cervical cytology screening. , 2009, Obstetrics and gynecology.

[42]  G. Garnett,et al.  ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES , 2006 .

[43]  Peter Szilagyi,et al.  Patient reminder and patient recall systems to improve immunization rates. , 2005, The Cochrane database of systematic reviews.

[44]  R. Hayes,et al.  Cancer Causes & Control , 2004, Cancer Causes & Control.

[45]  S. Swider,et al.  Outcome effectiveness of community health workers: an integrative literature review. , 2002, Public health nursing.

[46]  L E Rodewald,et al.  Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. , 2000, American journal of preventive medicine.

[47]  Abigail Shefer,et al.  Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults 1 2 , 2000 .

[48]  U. G. Dailey.  Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.